LATEST
26 January 2021
The initial concern that nervousness over the new vaccines would slow uptake doesn’t seem to have become a reality in the early days of COVID-19 immunisation, although it will be critical to maintain vaccine confidence, suggests an IPSOS poll.
MOST READ
20 January 2021
1 June 2020
FEATURED
3 September 2020 – Article
By Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance
13 October 2020
The initial concern that nervousness over the new vaccines would slow uptake doesn’t seem to have become a reality in the early days of COVID-19 immunisation, although it will be critical to maintain vaccine confidence suggests an IPSOS poll.
Scientists have observed that 501Y.V2 has quickly become "dominant" among multiple variants that have been circulating in the South African population.
It’s time-consuming but worthwhile: Residents respond to messages about Covid testing and vaccines when outreach teams speak their language and make a personal connection.
Source: COVID-19 Vaccine Tracker